Price Alert

Pediatrix Medical Group I... (MD)

NYSE: MD · Real-Time Price · USD

15.54

0.04 (0.26%)

At close: Aug 14, 2025, 3:59 PM

15.54

0.03%

After-hours: Aug 14, 2025, 05:54 PM EDT

0.26% (1D)

Bid	15.31
Market Cap	1.35B
Revenue (ttm)	1.94B
Net Income (ttm)	109.92M
EPS (ttm)	1.3
PE Ratio (ttm)	11.95
Forward PE	8.01
Analyst	Hold

Ask	15.77
Volume	515,763
Avg. Volume (20D)	834,603
Open	15.47
Previous Close	15.50
Day's Range	15.27 - 15.64
52-Week Range	10.02 - 17.67
Beta	1.21

About MD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Pediatrix Medical has released their quartely earnings on Aug 5, 2025:

Revenue of $468.84M misses estimates by $9.31M, with -7.03% YoY decline.

EPS of 0.53 exceeds estimates by 0.12, with 55.88% YoY growth.

Next Earnings Release

Pediatrix Medical Group Inc. is scheduled to release its earnings on Oct 31, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+5.04%

Pediatrix Medical Group shares are trading higher ... Unlock content with Pro Subscription

3 months ago

+11.81%

Pediatrix Medical Group shares are trading higher after the company reported a Q1 adjusted EPS and revenue beat.

News

1 day ago · zacks.com

Pediatrix Medical Group (MD) Is Attractively Priced Despite Fast-paced Momentum

Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but ar...

2 days ago · zacks.com

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 week ago · zacks.com

Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes

MD's Q2 earnings benefit from higher patient volumes and a declining expense level. It now projects 2025 adjusted EBITDA within $245-$255 million, up from the prior view of $220-$240 million.

1 week ago · fool.com

Pediatrix (MD) Q2 EPS Jumps 56%

Pediatrix Medical Group (MD 5.04%), a leader in neonatal and maternal-fetal healthcare services, reported its second-quarter 2025 earnings on August 5, 2025. The company delivered a standout quarter, ...

1 week ago · seekingalpha.com

Pediatrix Medical Group, Inc. (MD) Q2 2025 Earnings Call Transcript

Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Kasandra H. Rossi - Executive VP, Treasurer & CFO Mark S.

1 week ago · zacks.com

Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.34 per share a year ago.

1 week ago · businesswire.com

Pediatrix Medical Group Reports Second Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.

3 weeks ago · businesswire.com

Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025.

1 month ago · zacks.com

Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago · businesswire.com

Pediatrix Board Appoints Kurt D. Newman, M.D.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director.

Load More News